The abstract is read at the publisher; the summary is JClub's.
Mucosal IFN-λ delivery abrogates HSV-2-induced vaginal tissue pathology in mice lacking type I IFN signaling by drastically inhibiting IL-6 production.
- Why it matters: IFN-λ is known for mucosal antiviral effects and immune regulation, but the cellular and molecular mechanisms balancing these roles during viral infection are unclear.
- What they did: In a genital HSV-2 mouse model, IFN-λ enhanced CCR2+Ly6Chi differentiation into monocyte-derived antigen-presenting cells, and CCR2+ cell depletion removed the T cell–boosting effect.
- The result: IFN-λ also rescued local CD4+ T cell–dependent IFN-γ production, which is essential for protection against toxic megacolon after genital HSV-2 infection.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.